Pubblicazioni

Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: a systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

2021 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

De Felice, F.; Belgioia, L.; Alterio, D.; Bonomo, P.; Maddalo, M.; Paiar, F.; Denaro, N.; Corvo, R.; Merlotti, A.; Bossi, P.; Pappagallo, G. L.; D' Angelillo, R. M.; Magrini, S. M.; Arcangeli, S.

Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment. A mono-institutional experience

2019 - RADIATION ONCOLOGY

Valeriani, M.; Marinelli, L.; MacRini, S.; Reverberi, C.; Aschelter, A. M.; De Sanctis, V.; Marchetti, P.; Tronnolone, L.; Osti, M. F.